Hadassah

Gender Makes Difference in Medicine

Tuesday, Feb 9 2016

“Gender, biological sex, and sex hormones affect each and every facet of the practice of medicine,” Dr. Anat Biegon, visiting lecturer at the Hadassah Medical Center, told her audience. “They affect the prevalence of disease, disease presentation, disease outcomes, response to medical devices and procedures and, in a major way, response to drugs.”

In her presentation entitled “Sex Differences in Medicine: Why Should We Care?” Dr. Biegon, Professor of Neurology and Radiology and Director of the Center on Gender, Hormones, and Health at Stony Brook (NY) University School of Medicine, emphasized also the importance of taking the age of a woman into account. During the course of a woman’s life, she explained, as a woman’s reproductive hormones fluctuate, the risk of disease can rise and ebb.

Dr. Biegon stressed too that “Women are more likely to suffer adverse effects from drugs across drug classes.”  By the same token, she brought out, “many drugs are likely to be ineffective in women.” She cited the large study of 40,000 women which revealed that taking aspirin does help prevent heart attacks in women, but only for those over 65, despite the fact that it has a significant preventative effect for all men.

Read more about her lecture in The Jerusalem Post.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Aug 16 2017

Hadassah Removes Tumor;
Gazan Boy Walks for First Time

Unable to stand on his feet, suffering from severe respiratory distress, a four-year-old boy from Gaza gained the ability to walk once Hadassah Hospital surgeons identified and removed a large tumor lodged in his chest.

READ MORE ›
alt_text

Wednesday, Aug 16 2017

Hadassah Hosts Health Innovation Conference

Over one hundred doctors, researchers, and entrepreneurs gathered at Hadassah Hospital Ein Kerem this summer to discuss how to advance the quality of patient care with computational power.

READ MORE ›
alt_text

Monday, Aug 14 2017

Hadassah Hosts First Human Trial with Drug to Fight Nasty Bacterial Infection

Immuron, an Australian biopharmaceutical company, has received approval from the Hadassah Medical Organization’s ethics committee and Israel’s Ministry of Health to begin its first clinical trial with a new drug to fight a bacterial infection called Clostridium Difficile (CDI).

READ MORE ›
alt_text

Thursday, Aug 3 2017

Mystery of Devastating Pediatric Disease Solved by Hadassah Team

A genetic mutation causing a rare and devastating pediatric neurological disease that has puzzled medical centers around the world has been identified at the Hadassah Medical Organization by Prof. Orly Elpeleg, head of Hadassah's Department of Genetics and Metabolic Diseases.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More